These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 24002898)
1. Asymmetric dimethylarginine (ADMA) and soluble vascular cell adhesion molecule 1(sVCAM-1) as circulating markers for endothelial dysfunction in patients with pheochromocytoma. Vasilev V; Matrozova J; Elenkova A; Vandeva S; Kirilov G; Zacharieva S Exp Clin Endocrinol Diabetes; 2013 Oct; 121(9):551-5. PubMed ID: 24002898 [TBL] [Abstract][Full Text] [Related]
2. Interrelationship of Multiple Endothelial Dysfunction Biomarkers with Chronic Kidney Disease. Chen J; Hamm LL; Mohler ER; Hudaihed A; Arora R; Chen CS; Liu Y; Browne G; Mills KT; Kleinpeter MA; Simon EE; Rifai N; Klag MJ; He J PLoS One; 2015; 10(7):e0132047. PubMed ID: 26132137 [TBL] [Abstract][Full Text] [Related]
3. Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure. Nanayakkara PW; Teerlink T; Stehouwer CD; Allajar D; Spijkerman A; Schalkwijk C; ter Wee PM; van Guldener C Kidney Int; 2005 Nov; 68(5):2230-6. PubMed ID: 16221223 [TBL] [Abstract][Full Text] [Related]
4. Changes in serum asymmetric dimethylarginine and endothelial markers levels with varying periods of hemodialysis. Yaman A; Karabag F; Demir S; Koken T Ther Apher Dial; 2014 Aug; 18(4):361-7. PubMed ID: 25117882 [TBL] [Abstract][Full Text] [Related]
5. Elevated plasma asymmetric dimethylarginine levels in children with beta-thalassemia major may be an early marker for endothelial dysfunction. Gursel O; Tapan S; Sertoglu E; Taşçılar E; Eker I; Ileri T; Uysal Z; Kurekci AE Hematology; 2018 Jun; 23(5):304-308. PubMed ID: 29086658 [TBL] [Abstract][Full Text] [Related]
6. Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension. Curgunlu A; Uzun H; Bavunoğlu I; Karter Y; Genç H; Vehid S J Hum Hypertens; 2005 Aug; 19(8):629-33. PubMed ID: 15829997 [TBL] [Abstract][Full Text] [Related]
7. Circulating asymmetric dimethylarginine, endothelin-1 and cell adhesion molecules in women with gestational diabetes. Telejko B; Zonenberg A; Kuzmicki M; Modzelewska A; Niedziolko-Bagniuk K; Ponurkiewicz A; Nikolajuk A; Gorska M Acta Diabetol; 2009 Dec; 46(4):303-8. PubMed ID: 19139802 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial cell activation associated with increased plasma asymmetric dimethyl arginine in children and young adults with hypertension: a basis for atheroma? Goonasekera CD; Shah V; Rees DD; Dillon MJ Blood Press; 2000; 9(1):16-21. PubMed ID: 10854003 [TBL] [Abstract][Full Text] [Related]
9. Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension. Perticone F; Sciacqua A; Maio R; Perticone M; Maas R; Boger RH; Tripepi G; Sesti G; Zoccali C J Am Coll Cardiol; 2005 Aug; 46(3):518-23. PubMed ID: 16053968 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelium is the organ chiefly responsible for the catabolism of plasma asymmetric dimethylarginine--an explanation for the elevation of plasma ADMA in disorders characterized by endothelial dysfunction. McCarty MF Med Hypotheses; 2004; 63(4):699-708. PubMed ID: 15325021 [TBL] [Abstract][Full Text] [Related]
11. Lack of association between asymmetric dimethylarginine and in vivo microvascular and macrovascular endothelial function in patients with rheumatoid arthritis. Sandoo A; Dimitroulas T; Veldhuijzen van Zanten JJ; Smith JP; Metsios GS; Nightingale P; Stavropoulos-Kalinoglou A; Kitas GD Clin Exp Rheumatol; 2012; 30(3):388-96. PubMed ID: 22410121 [TBL] [Abstract][Full Text] [Related]
12. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus. Oğuz A; Uzunlulu M; Yorulmaz E; Yalçin Y; Hekim N; Fici F Anadolu Kardiyol Derg; 2007 Dec; 7(4):383-7. PubMed ID: 18065333 [TBL] [Abstract][Full Text] [Related]
13. Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease. Schnog JB; Teerlink T; van der Dijs FP; Duits AJ; Muskiet FA; Ann Hematol; 2005 May; 84(5):282-6. PubMed ID: 15599544 [TBL] [Abstract][Full Text] [Related]
14. Endothelial dysfunction, ADMA and insulin resistance in essential hypertension. Perticone F; Sciacqua A; Maio R; Perticone M; Galiano Leone G; Bruni R; Di Cello S; Pascale A; Talarico G; Greco L; Andreozzi F; Sesti G Int J Cardiol; 2010 Jul; 142(3):236-41. PubMed ID: 19168237 [TBL] [Abstract][Full Text] [Related]
15. Cigarette smoking and hypertension influence nitric oxide release and plasma levels of adhesion molecules. Mazzone A; Cusa C; Mazzucchelli I; Vezzoli M; Ottini E; Ghio S; Tossini G; Pacifici R; Zuccaro P Clin Chem Lab Med; 2001 Sep; 39(9):822-6. PubMed ID: 11601680 [TBL] [Abstract][Full Text] [Related]
16. Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients. Pasini AF; Garbin U; Stranieri C; Boccioletti V; Mozzini C; Manfro S; Pasini A; Cominacini M; Cominacini L Am J Hypertens; 2008 Nov; 21(11):1251-7. PubMed ID: 18772860 [TBL] [Abstract][Full Text] [Related]
17. A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria. Sibal L; Agarwal SC; Schwedhelm E; Lüneburg N; Böger RH; Home PD Cardiovasc Diabetol; 2009 Jun; 8():27. PubMed ID: 19486510 [TBL] [Abstract][Full Text] [Related]
18. Carotid intima-media thickness and plasma asymmetric dimethylarginine in Mexican children exposed to inorganic arsenic. Osorio-Yáñez C; Ayllon-Vergara JC; Aguilar-Madrid G; Arreola-Mendoza L; Hernández-Castellanos E; Barrera-Hernández A; De Vizcaya-Ruiz A; Del Razo LM Environ Health Perspect; 2013 Sep; 121(9):1090-6. PubMed ID: 23757599 [TBL] [Abstract][Full Text] [Related]